NEW YORK, March 4, 2015 /PRNewswire/ -- Securities
lawyers at Dunnam & Dunnam are investigating allegations for
Natus Medical Inc. shareholders (NASDAQ: BABY). Concerned BABY
investors who purchased between April 23,
2014 and March 2, 2015 are
encouraged to contact securities attorney Hamilton Lindley by
clicking here.
The law firm's investigation will focus on potential violations
of the federal securities laws. Natus Medical announced on
March 3, 2015, material weakness due
to aggregation of control deficiencies resulting from a lack of
timely risk assessment and monitoring of internal controls. As a
result, Natus Medical announced that it would be unable to file its
annual report on Form 10-K in a timely manner. As a result of
this announcement, on March 3, 2015,
shares of Natus Medical are down $1.31, or almost 4%, currently trading at
$34.02.
Dunnam & Dunnam has significant experience representing
shareholders in securities lawsuits nationwide. BABY stockholders –
or anyone with knowledge about this situation – should contact
lawyer Hamilton Lindley at hlindley@dunnamlaw.com with questions,
toll free at (844) 702-2990 or visit
http://www.dunnamlaw.com/BABY.
Find these Waco personal injury attorneys, trucking accident
attorneys and car wreck attorneys on Google+, Facebook, Twitter and
LinkedIn.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/natus-medical-inc-investors-encouraged-to-contact-securities-law-firm-about-investigation-into-allegations-of-corporate-wrongdoing-300045606.html
SOURCE Dunnam & Dunnam